This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Novartis AG (NVS)

NYSE: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 3.07B 13.02B 6.69B 5.55B
Receivables 11.17B 8.28B 10.06B 10.05B
Inventories 6.23B 6.09B 7.27B 6.74B
Other Current Assets 1.60B 9.33B 4.00B 3.09B
Total Current Assets 22.84B 37.56B 30.54B 28.00B
Property, Plant & Equipment, Gross 31.45B 31.43B 35.46B 32.77B
Accumulated Depreciation & Depletion 15.47B 15.45B 17.26B 15.83B
Property, Plant & Equipment, Net 15.98B 15.98B 18.20B 16.94B
Intangibles 34.22B 23.83B 27.84B 30.33B
Other Non-Current Assets 18.38B 10.71B 11.27B 10.46B
Total Non-Current Assets 108.71B 87.83B 95.71B 96.21B
Liabilities & Shareholder Equity
Total Assets 131.56B 125.39B 126.25B 124.22B
Accounts Payable 6.68B 5.90B 7.81B 7.11B
Short Term Debt 5.60B 6.61B 6.78B 5.95B
Other Current Liabilities 5.42B 7.91B 5.48B 7.90B
Total Current Liabilities 23.71B 26.97B 26.37B 24.05B
Long Term Debt 16.33B 13.80B 11.24B 13.78B
Deferred Income Taxes 6.36B 6.10B 6.90B 7.29B
Other Non-Current Liabilities 8.04B 7.67B 7.27B 9.88B
Minority Interest 11.00M 70.00M 117.00M 113.00M
Total Non-Current Liabilities 30.80B 27.65B 25.54B 31.07B
Total Liabilities 54.51B 54.62B 51.91B 55.12B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 77.05B 70.77B 74.34B 69.09B
Common Par 0.00 0.00 0.00 0.00
Additional Paid In Capital 991.00M 1.00B 1.00B 1.00B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 76.16B 69.87B 73.43B 68.18B
Treasury Stock -101.00M -103.00M -89.00M -92.00M
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 93.37B 84.56B 85.58B 82.87B
Total Equity 77.05B 70.77B 74.34B 69.09B
Total Liabilities & Stock Equity 131.56B 125.39B 126.25B 124.22B
Total Common Shares Outstanding 2.37B 2.40B 2.43B 2.42B
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 303.10M 307.57M 280.11M 285.57M
Basic Weighted Shares Outstanding 2.40B 2.43B 2.44B 2.42B
Diluted Weighted Shares Outstanding 2.40B 2.43B 2.48B 2.44B
Number of Employees 118700 133413 135696 127724
Number of Part-Time Employees 0 0 0 0
NVS News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for NVS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 5 5
Moderate Buy 0 0 0 0
Hold 4 3 2 2
Moderate Sell 0 0 0 0
Strong Sell 2 1 1 1
GET NVS ANALYST REPORT

NVS Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs